Investors Analyze These 3 Healthcare Stocks Following Earnings

Pfizer Inc. (NYSE:PFE) reported its results for the first quarter.  Net income for Pfizer Inc. fell to $1.79 billion (24 cents per share) vs. $2.22 billion (28 cents per share) a year earlier. This is a decline of 19.3% from the year-earlier quarter. Revenue fell 6.6% to $15.4 billion from the year-earlier quarter. Pfizer Inc. reported adjusted net income of 58 cents per share. By that measure, the company beat the mean estimate of 56 cents per share. Analysts were expecting revenue of $15.47 billion.

DENTSPLY International Inc. (NASDAQ:XRAY) in the first quarter as profit dropped from a year earlier. Net income for DENTSPLY International Inc. fell to $53.3 million (37 cents per share) vs. $69.1 million (48 cents per share) a year earlier. This is a decline of 22.9% from the year-earlier quarter. Revenue rose 25.6% to $716.4 million from the year-earlier quarter. DENTSPLY International Inc. fell short of the mean analyst estimate of 52 cents per share. Analysts were expecting revenue of $718.7 million.

Hospira Inc. (NYSE:HSP) reported its results for the first quarter. Net income for Hospira Inc. fell to $40.2 million (24 cents per share) vs. $149.9 million (88 cents per share) a year earlier. This is a decline of 73.2% from the year-earlier quarter. Revenue fell 3.6% to $965.9 million from the year-earlier quarter. Hospira Inc. fell short of the mean analyst estimate of 46 cents per share. Analysts were expecting revenue of $951 million.

More from The Cheat Sheet